Recruiting
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
NCT07259707
- Conditions
- Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication Positive, Fit Patients, +8 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China